Emyria

Emyria (formerly Emerald Clinics) is a Perth-based ASX-listed data-backed drug development and care delivery company.

Emyria uses data sourced from its clinical services subsidiary Emerald Clinics, which was listed on the ASX in 2020 through an IPO.

Contact Details

Suite 3, 43 Oxford Close , WEST LEEDERVILLE WA 6007

1300 436 363

info@emyria.com

emyria.com

Lists and Charts

Share price

Emyria
Closing price for the last 90 trading days

View ASX Chart

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
1424^th	VRX Silica	-45.28%	-12.17%
1425^th	RMA Global	-45.48%	-35.15%
1426^th	Emyria	-45.7%	0%
1427^th	Strike Resources	-45.75%	-9.14%
1428^th	Next Science	-45.84%	-43.04%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Revenue

Rank		Company	#
117^th		Emyria	$4.82m
118^th		Adveritas	$4.76m
119^th	-	HITIQ	$4.75m
120^th		Harvest Technology Group	$4.38m

196 public companies - industrial WA ranked by total revenue

View Full List

Company Share Transactions

Company Activity

	NEW ROLE: Michael Winlo, Chief Scientific Officer	23 Jan 2025
	NEW ROLE: Greg Hutchinson, Executive Chair	23 Jan 2025
	NEWS: Tagged in Board Moves November 21, 2023	21 Nov 2023
	NEW ROLE: Greg Hutchinson, Non-Executive Chair	21 Nov 2023
	NEWS: Tagged in Board Moves November 13, 2023	13 Nov 2023

News Articles

Related Information

Access to our data for Emyria is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Emyria is included in 1 list - Public Companies - Industrial WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today